Download PDF
Synlett 2010(5): 796-800  
DOI: 10.1055/s-0029-1219352
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthetic Route Optimization of PF-00868554, An HCV Polymerase Inhibitor in Clinical Evaluation

Sarah Johnson, Matt Drowns, John Tatlock, Angelica Linton, Javier Gonzalez, Robert Hoffman, Tanya Jewell, Leena Patel, Julie Blazel, Mingnam Tang, Hui Li*
Pfizer Global Research & Development, 10770 Science Center Drive, San Diego, CA 92121, USA
Fax: +1(877)4819190; e-Mail: hui.li@pfizer.com;
Further Information

Publication History

Received 7 December 2009
Publication Date:
25 January 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

This paper describes the optimization efforts to establish an enabling synthesis to provide multigram quantity of PF-00868554, an HCV polymerase inhibitor currently in phase II clinical evaluations.

Key words

HCV polymerase inhibitor - Heck reaction - dihydro­pyrone - pyridine synthesis - borane pyridine

    References and Notes

  • 1 Sarbah SA. Younossi ZM. J. Clin. Gastroenterol.  2000,  30:  125 
    CrossrefGoogle Scholar
  • 2 Hayashi N. Takehara T. J. Gastroenterol.  2006,  41:  17 
    CrossrefGoogle Scholar
  • 3 Lohmann V. Korner F. Koch J. Herian U. Theilmann L. Bartenschlager R. Science  1999,  285:  110 
    CrossrefGoogle Scholar
  • 4 Li H. Tatlock J. Linton A. Gonzalez J. Jewell T. Patel L. Ludlum S. Drowns M. Rahavendran SV. Skor H. Hunter R. Shi ST. Herlihy KJ. Parge H. Hickey M. Yu X. Chau F. Nonomiya J. Lewis C. J. Med. Chem.  2009,  52:  1255 
    CrossrefGoogle Scholar
  • 5 Li H. Tatlock J. Linton A. Gonzalez J. Borchardt A. Dragovich P. Jewell T. Prins T. Zhou R. Blazel J. Parge H. Love R. Hickey M. Doan C. Shi S. Duggal R. Lewis C. Fuhrman S. Bioorg. Med. Chem. Lett.  2006,  16:  4834 
    CrossrefGoogle Scholar
  • 6 Li H. Linton A. Tatlock J. Gonzalez J. Borchardt A. Abreo M. Jewell T. Patel L. Drowns M. Ludlum S. Goble M. Yang M. Blazel J. Rahavendran R. Skor H. Shi S. Lewis C. Fuhrman S. J. Med. Chem.  2007,  50:  3969 
    CrossrefGoogle Scholar
  • 7 Sonogashira K. Tohda Y. Hagihara N. Tetrahedron Lett.  1975,  16:  4467 
    CrossrefGoogle Scholar
  • 8 Camp D. Matthews CF. Neville ST. Rouns M. Scott RW. Truong Y. Org. Process Res. Dev.  2006,  10:  814 
    CrossrefGoogle Scholar
  • 9 Jeffery T. J. Chem. Soc., Chem. Commun.  1984,  1287 
    CrossrefGoogle Scholar
  • 10 Beletskaya IP. Cheprakov AV. Chem. Rev.  2000,  100:  3009 
    Google Scholar
  • 11 Deshapande SS. J. Indian Chem. Soc.  1932,  9:  303 
    Google Scholar
12

Experimental Conditions of Optimized Heck Coupling and Product Characterization
To a solution of benzyl ester 15 (1.30 g, 4.74 mmol) in DMAC (11 mL) in a two-neck round-bottomed flask was added 4-bromo-2,6-diethylpyridine (7, 1.22 g, 5.69 mmol), followed by TBACl (1.30 g, 4.74 mmol), and Pd(OAc)2. The resulting solution was degassed by house vacuum followed by argon back filling (3×). Dicyclohexylmethylamine (2.0 mL, 9.50 mmol) was added, and the reaction vessel was lowered into a pre-heated oil bath at 90 ˚C. The reaction was stirred at this temperature under argon until all benzyl ester 15 was consumed (about 5 h). The solution was cooled to r.t., diluted with H2O (60 mL) and then extracted with MTBE
(2 × 50 mL). The combined organic layers were washed with H2O (2 × 50 mL), sat. NaHCO3 (50 mL), 5% aq AcOH (50 mL), then brine (sat., 50 mL). The yellow solution was dried (MgSO4), filtered, and concentrated to provide a crude amber oil (2.1 g). ¹H NMR (300 MHz, CDCl3): δ = 1.26-1.32 (m, 6 H), 1.48-1.64 (m, 8 H), 2.71-2.74 (m, 2 H), 2.75-2.84 (m, 5 H), 5.02-5.07 (m, 1 H), 5.10-5.12 (m, 1 H), 6.35-6.42 (m, 1 H), 6.51-6.59 (m, 1 H), 6.89 (s, 2 H), 7.22-7.26 (m, 5 H). MS (APCI): m/z = 408.20 [M + H]+.

13

Experimental Conditions for Scheme 3, Step viii
To a solution of pyrone 19 (710 mg, 2.07 mmol) in anhyd MeOH (10 mL) at -25 ˚C was added borane-pyridine complex (ca. 8 M solution, 0.5 mL, 4.13 mmol). To this aldehyde (1.3 equiv, 2.69 mmol, 475 mg) was added, and the reaction was slowly warmed to 0 ˚C. The cloudy mixture was stirred for 3 h during which time it became homogen-eous. H2O (1 mL) was added to quench the remaining borane. The reaction was stirred for an additional 30 min before it was concentrated to about 1/10 volume and diluted in 10% MeOH-EtOAc. The mixture was extracted with 1 N HCl (2×), and the combined aqueous layers were carefully neutralized to pH 7 with sat. NaHCO3. The aqueous layer was extracted with 10% MeOH-EtOAc (3×), and the resulting organic extract showed a single peak with mass corresponding to the product. The organic layer was washed with brine and dried (MgSO4), filtered, and concentrated to a white solid (789 mg, 76%). ¹H NMR (300 MHz, CDCl3): δ = 1.23 (t, J = 7.63 Hz, 6 H), 1.48-1.59 (m, 4 H), 1.59-1.75 (m, 4 H), 1.96-2.09 (m, 4 H), 2.38 (d, J = 8.48 Hz, 1 H), 2.63-2.67 (m, 4 H), 2.69-2.80 (m, 9 H), 4.06-4.15 (m, 2 H), 6.76 (s, 2 H), 6.83 (s, 1 H). MS (APCI): m/z = 504.2 [M + H]+.